Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

World Biggest Tenders Source

This tender with title Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens. has been published on Bidding Source portal dated 18 Oct 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

Tender Type :

Contract notice

Reference No. :

2019/S 201-487851

Country :

Germany

Province/City :

Germany-Hanover

Publish Date :

18 Oct 2019

Closing Date :

31 Dec 2021

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Drug discount contracts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) within the framework of open-house procedures - 636646 Germany Drug rebate agreements from 01.11.2026 for various active ingredients within the framework of an open-house procedure - 635398 Germany Open House Original Discount Contracts 2025-08 - Roxadustat - 634308 Germany Medicine containing the active ingredient combination oxycodone and naloxone (ATC: N02AA55) - 634105 Germany Medicinal product containing the active ingredient dimethyl fumarate (ATC: L04AX07) - 634611 Germany Medicinal product containing the active ingredient rivaroxaban (ATC: B01AF01 - in all strengths except 2.5 mg per unit oral dosage form) - 634832 Germany Medicine containing the active ingredient ticagrelor (ATC: B01AC24) - 634889 Germany Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient Nadroparin, ATC B01AB06, valid from 01.11.26 to 31.10.28 (plus option for 1 x 12 months) - 640827 Germany Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient cinacalcet (exclusively in the standard size N3), ATC H05BX01, valid from 01.11.26 to 31.10.28 (plus option for 1 x 12 months) - 640982 Germany Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient thalidomide, ATC L04AX02, valid from 01.11.26 to 31.10.28 (plus option for 1x12 months) - 642751 Germany

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com